2024.07

The company has become a subsidiary of Baiyang Pharmaceutical (SZ.301015).

2023.06

The company was merged into Shanghai Baiyang Pharmaceutical Co., Ltd.

2021.08

Passed the evaluation and identification of the integrated management system of the two modernizations.

2018.11

Won the national "Major New Drug Creation" scientific and technological major project approval.

2018.04

Won the approval of the key R & D plan (major scientific and technological innovation project) of Shandong Province.

2017.12

It has been identified by the National Health and Family Planning Commission as one of the pharmaceutical companies undertaking the national major topics of the 13th Five-Year Plan. It has become the only pharmaceutical company selected for the topic in Qingdao City and one of the only three companies in Shandong Province.

2016.10

Zero defects passed the U.S. FDA's cGMP inspection for the first time.

2015.01

Passed the renewal of the Drug Production License and GMP certification inspection

2014.06

Jimo's new factory was officially opened.

2005.12

Qingdao Baiyang Pharmaceutical Co., Ltd. changed its name for industrial and commercial registration.